Offering some relief for people suffering from prostate cancer, Starpharma (ASX: SPL) might be on the verge of a breakthrough as it announced that its drug DEP® cabazitaxel has shown promising anti-tumour activity data at the European Society of Medical Oncology (ESMO) Congress in Paris, France. The new data from its phase 2 trial reveals
Read More
Having tripled their network of allied healthcare businesses since listing on the ASX four years ago to now be operating 309 businesses, Healthia (ASX: HLA) is on the move again with institutional investors keen for a bigger slice of the pie by backing the company with $10 million to accelerate its growth. The $10 million
Read More
If you have fever dreams about felons escaping prison and breaking into your home, peaceful nights lay ahead as Government-backed venture builder Strategic Elements (ASX: SOR) has signed an agreement with software industrial company Honeywell to deploy automation and robotics Company Stealth Technologies’ Autonomous Security Vehicles (ASVs) for perimeter security. Stealth will engage exclusively with
Read More
The North American sports betting industry continues to scale to new highs as punters in Maryland have now gained access to sports betting with PointsBet (ASX: PBH), which continues its national expansion. Punters from Maryland have recently seen a considerable change in their access to retail sports betting following new legislation signed by Maryland Gov.
Read More
After the Human Research Ethics Committee (HREC) rejected the Company’s flagship drug, EmtinB, knocking back years of research in the process, disappointed CEO and Managing Director, Mr Matt Liddelow, announced that he is resigning from his position immediately. Liddelow noted, “I acknowledge the loss in shareholder value as a result of the rejected Human Research
Read More
What do you do when you lose nearly $100 million in only six months? Re-evaluate everything. That’s exactly what defence, space and communications company Electro Optic Systems (ASX: EOS) is doing as it expresses disappointment in its first half result, losing $98.9 million in six months ending June 30, 2022. The loss is even more
Read More